Medication adherence among adults prescribed imatinib, dasatinib, or nilotinib for the treatment of chronic myeloid leukemia.
about
Oral antineoplastic agents: how do we care about adherence?Quality of Life and Long-Term Therapy in Patients with Chronic Myeloid LeukemiaAcute lymphoblastic leukemia in adolescents and young adults.Understanding and Challenges in Taking Tyrosine Kinase Inhibitors among Malaysian Chronic Myeloid Leukemia Patients: A Qualitative StudyChronic Myeloid Leukemia-the Promise of Tyrosine Kinase Inhibitor Discontinuation.
P2860
Medication adherence among adults prescribed imatinib, dasatinib, or nilotinib for the treatment of chronic myeloid leukemia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Medication adherence among adu ...... t of chronic myeloid leukemia.
@en
Medication adherence among adu ...... t of chronic myeloid leukemia.
@nl
type
label
Medication adherence among adu ...... t of chronic myeloid leukemia.
@en
Medication adherence among adu ...... t of chronic myeloid leukemia.
@nl
prefLabel
Medication adherence among adu ...... t of chronic myeloid leukemia.
@en
Medication adherence among adu ...... t of chronic myeloid leukemia.
@nl
P2093
P2860
P356
P1476
Medication adherence among adu ...... t of chronic myeloid leukemia.
@en
P2093
Carole R Chambers
Frances Cusano
Kristin R Anderson
M Lynn Savoie
Nadine Lam
Naureen Sheikh
Patrick S Yau
P2860
P356
10.1177/1078155213520261
P577
2014-02-06T00:00:00Z